2 Result: LivaNova
Q2 Earnings Breakthrough: LivaNova and Owens Corning Exceed Forecasts
July 26th, 2023
LivaNova PLC (Nasdaq: LIVN) reported a robust second-quarter 2023 adjusted earnings per share (EPS) of $0.78, surpassing the consensus estimate of $0.54. The company also raised its full-year 2023 guidance for adjusted EPS to a range of $2.5. Read more
Lucintel Forecasts Neuroprosthetic Market to grow at a CAGR of 12% from 2019 to 2024
December 09th, 2021
Dallas, TX / CRWE PRESS RELEASE / Dec. 9, 2021 - According to the recent study the Neuroprosthetic Market is projected to grow at a CAGR of 12% from 2019 to 2024. Growth in this market is primarily driven by increasing number of patients sufferi. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login